Literature DB >> 2272220

Esophageal motility, heartburn, and gastroesophageal reflux: variations in clinical presentation of esophageal dysphagia.

D L Decktor1, M L Allen, M Robinson.   

Abstract

Dysphagia is a potentially important symptom, often leading to the finding of an anatomical or motility disorder of the esophagus. Dysphagia and heartburn represent two of the most common symptoms associated with esophageal motility disorders. To explore the relationship of symptomatic esophageal dysphagia and heartburn and their association with primary esophageal motor disorders, we have performed a retrospective assessment of 1035 patient evaluations performed at our gastrointestinal laboratory. A clear statistical association of symptomatic dysphagia and heartburn was established; however, no pattern diagnostic of a specific motility disorder was discernible. A sizable fraction of our patient population with dysphagia demonstrated normal esophageal motility. A significant portion of dyspeptic patients exhibited both normal motility and acid exposure. The differences observed between the incidence of subjective symptoms and objective dysfunction may be explained in part by an altered or increased esophageal sensitivity of these patients.

Entities:  

Mesh:

Year:  1990        PMID: 2272220     DOI: 10.1007/bf02412689

Source DB:  PubMed          Journal:  Dysphagia        ISSN: 0179-051X            Impact factor:   3.438


  13 in total

1.  Comparison of experimental esophageal pain with clinical pain of angina pectoris and esophageal disease.

Authors:  P KRAMER; W HOLLANDER
Journal:  Gastroenterology       Date:  1955-11       Impact factor: 22.682

2.  A clinical test for esophagitis.

Authors:  L M BERNSTEIN; L A BAKER
Journal:  Gastroenterology       Date:  1958-05       Impact factor: 22.682

3.  Flow charts, diagnostic keys, and algorithms in the diagnosis of dysphagia.

Authors:  D A Edwards
Journal:  Scott Med J       Date:  1970-10       Impact factor: 0.729

4.  Rectal distensibility in the irritable bowel syndrome.

Authors:  G Kullmann; J F Fielding
Journal:  Ir Med J       Date:  1981-05

5.  Abnormal sensory perception in patients with esophageal chest pain.

Authors:  J E Richter; C F Barish; D O Castell
Journal:  Gastroenterology       Date:  1986-10       Impact factor: 22.682

6.  Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome.

Authors:  J Ritchie
Journal:  Gut       Date:  1973-02       Impact factor: 23.059

Review 7.  Esophageal motility disorders.

Authors:  J B Nelson; D O Castell
Journal:  Dis Mon       Date:  1988-06       Impact factor: 3.800

8.  Prospective manometric evaluation with pharmacologic provocation of patients with suspected esophageal motility dysfunction.

Authors:  S B Benjamin; J E Richter; C M Cordova; T E Knuff; D O Castell
Journal:  Gastroenterology       Date:  1983-05       Impact factor: 22.682

9.  Radionuclide transit: a sensitive screening test for esophageal dysfunction.

Authors:  C O Russell; L D Hill; E R Holmes; D A Hull; R Gannon; C E Pope
Journal:  Gastroenterology       Date:  1981-05       Impact factor: 22.682

10.  Manometric responses to balloon distention in patients with nonobstructive dysphagia.

Authors:  W K Deschner; K A Maher; E L Cattau; S B Benjamin
Journal:  Gastroenterology       Date:  1989-11       Impact factor: 22.682

View more
  3 in total

1.  Manometric diagnosis of diffuse esophageal spasm.

Authors:  M L Allen; A J DiMarino
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

2.  Refundoplication for recurrent gastroesophageal reflux.

Authors:  M E Luostarinen; J O Isolauri; M O Koskinen; J O Laitinen; M J Matikainen; T S Lindholm
Journal:  World J Surg       Date:  1993 Sep-Oct       Impact factor: 3.352

3.  Liver X Receptor Agonist Modifies the DNA Methylation Profile of Synapse and Neurogenesis-Related Genes in the Triple Transgenic Mouse Model of Alzheimer's Disease.

Authors:  A G Sandoval-Hernández; H G Hernández; A Restrepo; J I Muñoz; G F Bayon; A F Fernández; M F Fraga; G P Cardona-Gómez; H Arboleda; Gonzalo H Arboleda
Journal:  J Mol Neurosci       Date:  2015-11-09       Impact factor: 3.444

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.